» Articles » PMID: 30105384

Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years

Abstract

Importance: Rotavirus infection is the global leading cause of diarrhea-associated morbidity and mortality among children younger than 5 years.

Objectives: To examine the extent of rotavirus infection among children younger than 5 years by country and the number of deaths averted because of the rotavirus vaccine.

Design, Setting, And Participants: This report builds on findings from the Global Burden of Disease Study 2016, a cross-sectional study that measured diarrheal diseases and their etiologic agents. Models were used to estimate burden in data-sparse locations.

Exposure: Diarrhea due to rotavirus infection.

Main Outcomes And Measures: Rotavirus-associated mortality and morbidity by country and year and averted deaths attributable to the rotavirus vaccine by country.

Results: Rotavirus infection was responsible for an estimated 128 500 deaths (95% uncertainty interval [UI], 104 500-155 600) among children younger than 5 years throughout the world in 2016, with 104 733 deaths occurring in sub-Saharan Africa (95% UI, 83 406-128 842). Rotavirus infection was responsible for more than 258 million episodes of diarrhea among children younger than 5 years in 2016 (95% UI, 193 million to 341 million), an incidence of 0.42 cases per child-year (95% UI, 0.30-0.53). Vaccine use is estimated to have averted more than 28 000 deaths (95% UI, 14 600-46 700) among children younger than 5 years, and expanded use of the rotavirus vaccine, particularly in sub-Saharan Africa, could have prevented approximately 20% of all deaths attributable to diarrhea among children younger than 5 years.

Conclusions And Relevance: Rotavirus-associated mortality has decreased markedly over time in part because of the introduction of the rotavirus vaccine. This study suggests that prioritizing vaccine introduction and interventions to reduce diarrhea-associated morbidity and mortality is necessary in the continued global reduction of rotavirus infection.

Citing Articles

Evaluation of Liposome-Encapsulated Vancomycin Against Methicillin-Resistant .

Erdene E, Munkhjargal O, Batnasan G, Dorjbal E, Oidov B, Byambaa A Biomedicines. 2025; 13(2).

PMID: 40002791 PMC: 11853440. DOI: 10.3390/biomedicines13020378.


Differential Effectiveness of Water, Sanitation, and Handwashing Interventions to Reduce Child Diarrhea in Dry and Rainy Seasons: A Systematic Review and Meta-Analysis of Intervention Trials.

Hubbard S, Wolf J, Oza H, Arnold B, Freeman M, Levy K Environ Health Perspect. 2025; 133(2):26001.

PMID: 39903556 PMC: 11793162. DOI: 10.1289/EHP14502.


Determinants of Rotavirus Vaccine Acceptance in an Area of Southern Italy with Low Vaccination Coverage: A Case-Control Study by the Health Belief Model Questionnaire.

Anza D, Esposito M, Bertolazzi G, Fallucca A, Genovese C, Maniscalco G Vaccines (Basel). 2025; 13(1).

PMID: 39852842 PMC: 11769460. DOI: 10.3390/vaccines13010063.


High Detection Rate of Rotavirus Infection Among Children Admitted with Acute Gastroenteritis to Six Public Hospitals in Luanda Province After the Introduction of Rotarix Vaccine: A Cross-Sectional Study.

Vita D, Lemos M, Neto Z, Evans M, Francisco N, Fortes F Viruses. 2025; 16(12.

PMID: 39772256 PMC: 11680217. DOI: 10.3390/v16121949.


Molecular Characterization and Pathogenicity Analysis of Porcine Rotavirus A.

Lv Y, Tong Z, Liu J, Zhang Z, Wang C, Zeng Y Viruses. 2025; 16(12.

PMID: 39772152 PMC: 11680200. DOI: 10.3390/v16121842.


References
1.
Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano C . Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010; 362(4):299-305. DOI: 10.1056/NEJMoa0905211. View

2.
. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1151-1210. PMC: 5605883. DOI: 10.1016/S0140-6736(17)32152-9. View

3.
Liu J, Platts-Mills J, Juma J, Kabir F, Nkeze J, Okoi C . Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016; 388(10051):1291-301. PMC: 5471845. DOI: 10.1016/S0140-6736(16)31529-X. View

4.
Chen S, Tan L, Huang L, Chen K . Rotavirus infection and the current status of rotavirus vaccines. J Formos Med Assoc. 2012; 111(4):183-93. DOI: 10.1016/j.jfma.2011.09.024. View

5.
Lanata C, Fischer-Walker C, Olascoaga A, Torres C, Aryee M, Black R . Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One. 2013; 8(9):e72788. PMC: 3762858. DOI: 10.1371/journal.pone.0072788. View